Multidimensional immune profiling of cutaneous lupus erythematosus in vivo stratified by patient response to antimalarials

…, M Sharma, Y Li, R Feng, G Sprow… - Arthritis & …, 2022 - Wiley Online Library
Objective The pathogenesis of cutaneous lupus erythematosus (CLE) is multifactorial, and
CLE is difficult to treat due to the heterogeneity of inflammatory processes among patients. …

[HTML][HTML] Bullous systemic lupus erythematosus in females

G Sprow, M Afarideh, J Dan, ML Hedberg… - International Journal of …, 2022 - journals.lww.com
Bullous systemic lupus erythematosus (BSLE) is a rare blistering presentation of systemic
lupus erythematosus, typically affecting women with the highest incidence in those of African …

Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist

C Stull, G Sprow, VP Werth - The Journal of rheumatology, 2023 - jrheum.org
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations
at some point in their disease course. The skin findings in SLE are classified as SLE-…

[HTML][HTML] Autoimmune skin disease exacerbations following COVID-19 vaccination

G Sprow, M Afarideh, J Dan, R Feng, E Keyes… - Frontiers in …, 2022 - frontiersin.org
Background Vaccination against COVID-19 reduces the risk of severe COVID-19 disease
and death. However, few studies have examined the safety of the COVID-19 vaccine in …

[HTML][HTML] Sclerotic skin disease development following COVID-19 vaccination

G Sprow, J Dan, J Abbott, A Jiang, DA Diaz… - JAAD Case Reports, 2022 - Elsevier
Discussion We present 2 cases with prior rheumatic cutaneous disease who progressed to
new-onset sclerotic skin disease following receipt of mRNA vaccines against COVID-19. To …

[HTML][HTML] Emerging therapies in cutaneous lupus erythematosus

G Sprow, J Dan, JF Merola, VP Werth - Frontiers in Medicine, 2022 - frontiersin.org
Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can occur with or
without underlying systemic lupus erythematosus (SLE) and often has a profoundly negative …

Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a pediatric normal tissue effects in the clinic normal …

…, PJ Taddei, LS Constine, G Sprow… - International Journal of …, 2022 - Elsevier
Purpose Radiation-induced cerebrovascular toxicity is a well-documented sequelae that
can be both life-altering and potentially fatal. We performed a meta-analysis of the relevant …

A comparison of the efficacy of Skindex-16 and Skindex-29 in dermatomyositis

J Dan, G Sprow, J Concha, J Patel… - British Journal of …, 2023 - academic.oup.com
Recently, more emphasis has been placed on patient-reported outcomes in clinical trials,
which has inadvertently led to an increase in respondent burden. In this study, we found that …

Distinguishing monkeypox from its mimickers.

G Sprow, M Toker, U Khanna, B Wu - Journal of Medical Virology, 2023 - europepmc.org
Herein, we present a simple guide to help clinicians distinguish monkeypox from other
common diseases with similar presentations along with the initial diagnostic workup for …

Plasmacytoid dendritic cells are not major producers of type 1 interferon in cutaneous lupus: An in depth immunoprofile of subacute and discoid lupus

…, F Chin, E Keyes, M Sharma, G Sprow… - Journal of Investigative …, 2023 - Elsevier
The immunologic drivers of cutaneous lupus erythematosus (CLE) and its clinical subtypes
remains poorly understood. We sought to characterize the immune landscape of discoid …